DAFNA Capital Management’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-181,675
| Closed | -$25.4M | – | 89 |
|
|
2018
Q4 | $25.4M | Buy |
181,675
+12,000
| +7% | +$1.82M | 12.65% | 1 |
|
|
2018
Q3 | $29M | Buy |
169,675
+11,000
| +7% | +$1.85M | 11.9% | 1 |
|
|
2018
Q2 | $27.5M | Sell |
158,675
-22,862
| -13% | -$3.44M | 12.89% | 1 |
|
|
2018
Q1 | $20.9M | Sell |
181,537
-114,463
| -39% | -$12.2M | 10.19% | 1 |
|
|
2017
Q4 | $24.9M | Buy |
296,000
+33,879
| +13% | +$2.82M | 13.42% | 1 |
|
|
2017
Q3 | $24.1M | Sell |
262,121
-41,500
| -14% | -$3.22M | 14.99% | 1 |
|
|
2017
Q2 | $24.3M | Buy |
303,621
+2,899
| +1% | +$161K | 17.37% | 1 |
|
|
2017
Q1 | $12.7M | Buy |
300,722
+161,000
| +115% | +$6.63M | 10.7% | 1 |
|
|
2016
Q4 | $4.49M | Buy |
139,722
+9,500
| +7% | +$244K | 3.94% | 4 |
|
|
2016
Q3 | $3.41M | Buy |
130,222
+28,256
| +28% | +$739K | 2.37% | 10 |
|
|
2016
Q2 | $2.36M | Buy |
101,966
+62,966
| +161% | +$1.57M | 1.87% | 15 |
|
|
2016
Q1 | $1.07M | Sell |
39,000
-22,737
| -37% | -$476K | 0.92% | 34 |
|
|
2015
Q4 | $1.76M | Buy |
61,737
+49,992
| +426% | +$1.34M | 1.57% | 19 |
|
|
2015
Q3 | $205K | Sell |
11,745
-500
| -4% | -$9.78K | 0.2% | 70 |
|
|
2015
Q2 | $221K | Buy |
+12,245
| New | +$167K | 0.19% | 64 |
|
Other funds holding LOXO
DAFNA Capital Management's LOXO Position: Q1 2019 in Review
DAFNA Capital Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 181,675 shares — an estimated $25.4M sold.
DAFNA Capital Management first reported a position in LOXO in Q2 2015 and held it in 15 quarters. The position peaked at $29M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- DAFNA Capital Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- DAFNA Capital Management sold 181,675 Loxo Oncology, Inc shares in Q1 2019, an estimated $25.4M.
- DAFNA Capital Management first reported a position in Loxo Oncology, Inc in Q2 2015 and held it in 15 quarters.
- DAFNA Capital Management's Loxo Oncology, Inc position peaked at $29M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on DAFNA Capital Management's 13F filing for Q1 2019, filed 15 May 2019.